1 year return (CAGR)
13.75%
Nektar Therapeutics Exchange (NASDAQ, USD)
NKTR
57.06
-0.26 (-0.39%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
364.58%
5 year return (CAGR)
32.49%
10 year return (CAGR)
13.61%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
2.28B
Price/Sales
41.81
Ent value
2.44B
Price/Book
2.53
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
31.34%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 68.53 |
| Daily high | 69.84 |
| Daily low | 66.71 |
| Daily Volume | 749K |
| All-time high | 108.44 |
| 1y analyst estimate | 144.40 |
| Beta | 1.16 |
| EPS (TTM) | -4.75 |
| Dividend per share | 0.00 |
| Ex-div date | 11 Jun 2014 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| NKTR | S&P500 | |
| Current price drop from All-time high | -47.38% | -0.84% |
| Highest price drop | -99.61% | -56.47% |
| Date of highest drop | 28 Nov 2023 | 9 Mar 2009 |
| Avg drop from high | -67.05% | -10.68% |
| Avg time to new high | 82 days | 12 days |
| Max time to new high | 4486 days | 1805 days |
News
